1-6 of 6
Kim E. Nichols
Close
Sort by
Journal Articles

ETV6 represses inflammatory response genes and regulates HSPC function during stress hematopoiesis in mice

Mackenzie Bloom, Ninad Oak, Rebekah Baskin-Doerfler, Ruopeng Feng, Ilaria Iacobucci, Pradyumna Baviskar, Xujie Zhao, Alexa N. Stroh, Chunliang Li, Patrick Ozark, Heather S. Tillman, Yichao Li, Katherine C. Verbist, Sabrin Albeituni, Danny C. Scott, Moeko T. King, Shannon L. McKinney-Freeman, Mitchell J. Weiss, Jun J. Yang, Kim E. Nichols
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5608–5623.
https://doi.org/10.1182/bloodadvances.2022009313
Published: 2023
Includes: Supplemental data
Journal Articles

Development of BRAF V600E -positive acute myeloid leukemia in a patient on long-term dabrafenib for multisystem LCH

Marta Salek, Ninad Oak, Melissa Hines, Jamie L. Maciaszek, Ruth Tatevossian, Akshay Sharma, Kim E. Nichols, Patrick Campbell
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2681–2684.
https://doi.org/10.1182/bloodadvances.2021006229
Published: 2022
Journal Articles

CPX-351 induces remission in newly diagnosed pediatric secondary myeloid malignancies

Clinical Trials & Observations
Yixin Hu, Kenneth J. Caldwell, Mihaela Onciu, Sara M. Federico, Marta Salek, Sara Lewis, Shaohua Lei, Jinghui Zhang, Kim E. Nichols, Clifford M. Takemoto, Brandon M. Triplett, Jason E. Farrar, Jeffrey E. Rubnitz, Raul C. Ribeiro, Marcin W. Wlodarski
Journal: Blood Advances
Blood Adv (2022) 6 (2): 521–527.
https://doi.org/10.1182/bloodadvances.2021006139
Published: 2022
Includes: Supplemental data
Journal Articles

Dasatinib induces a dramatic response in a child with refractory juvenile xanthogranuloma with a novel MRC1-PDGFRB fusion

Clinical Trials & Observations
Shaimaa S. Eissa, Michael R. Clay, Teresa Santiago, Gang Wu, Lu Wang, Barry L. Shulkin, Jennifer Picarsic, Kim E. Nichols, Patrick K. Campbell
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2991–2995.
https://doi.org/10.1182/bloodadvances.2020001890
Published: 2020
Journal Articles

ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants

Xi Luo, Simone Feurstein, Shruthi Mohan, Christopher C. Porter, Sarah A. Jackson, Sioban Keel, Michael Chicka, Anna L. Brown, Chimene Kesserwan, Anupriya Agarwal, Minjie Luo, Zejuan Li, Justyne E. Ross, Panagiotis Baliakas, Daniel Pineda-Alvarez, Courtney D. DiNardo, Alison A. Bertuch, Nikita Mehta, Tom Vulliamy, Ying Wang, Kim E. Nichols, Luca Malcovati, Michael F. Walsh, Lesley H. Rawlings, Shannon K. McWeeney, Jean Soulier, Anna Raimbault, Mark J. Routbort, Liying Zhang, Gabriella Ryan, Nancy A. Speck, Sharon E. Plon, David Wu, Lucy A. Godley
Journal: Blood Advances
Blood Adv (2019) 3 (20): 2962–2979.
https://doi.org/10.1182/bloodadvances.2019000644
Published: 2019
Includes: Supplemental data
Journal Articles

Enhancing the antitumor functions of invariant natural killer T cells using a soluble CD1d-CD19 fusion protein

Rupali Das, Peng Guan, Susan J. Wiener, Nishant P. Patel, Trevor G. Gohl, Elizabeth Evans, Maurice Zauderer, Kim E. Nichols
Journal: Blood Advances
Blood Adv (2019) 3 (5): 813–824.
https://doi.org/10.1182/bloodadvances.2018028886
Published: 2019
Includes: Supplemental data